Xiaodong Mei

Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)

Yunpeng Yang, Zhehai Wang, Jian Fang et al. · Journal of Thoracic Oncology · 2020 · 376 citations · Full text

Updated Overall Survival Data and Predictive Biomarkers of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC in the Phase 3 ORIENT-11 Study

Yunpeng Yang, Jiya Sun, Zhehai Wang et al. · Journal of Thoracic Oncology · 2021 · 141 citations · Full text

COVID-19 pandemic in Wuhan: Ambient air quality and the relationships between criteria air pollutants and meteorological variables before, during, and after lockdown

Ishaq Dimeji Sulaymon, Yuanxun Zhang, Philip K. Hopke et al. · Atmospheric Research · 2020 · 123 citations · Full text

Meteorology, Engineering, Air Pollution Climatology +13

Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China

Anwen Xiong, Lei Wang, Jianhua Chen et al. · The Lancet · 2025 · 90 citations

Medicine, Immunology, Pathology +6

Quantitative estimation of meteorological impacts and the COVID-19 lockdown reductions on NO2 and PM2.5 over the Beijing area using Generalized Additive Models (GAM)

Jinxi Hua, Yuanxun Zhang, B. de Foy et al. · Journal of Environmental Management · 2021 · 89 citations · Full text

Meteorology, Engineering, Air Pollution Climatology +11